Back to search

National and Kapodistrian University of Athens

The role of PD-1 in macrophage polarization and fate commitment

Abstract

dc:description

Background: PD-1 is a checkpoint receptor that has been shown to inactivate T cells through SHP-2 recruitment. However, tumor bearing mice with conditional deletion of SHP-2 in T cells did not demonstrate any differences in tumor progression compared to wild type mice. Both PD-1 and SHP-2 are also expressed in myeloid cells, including the myeloid cells progenitors. PD-1 deletion in myeloid cells can induce differentiation of myeloid progenitors towards mature myeloid cells, while SHP-2 gain- of-function mutations are known to be implicated in Acute Myelogenous Leukemia, by preventing differentiation, through dephosphorylation of IRF-8 and HOXA10. Nevertheless, no PD-1/SHP- 2 interaction has been described in primary healthy myelocytes. The goal of this study, is to investigate the PD-1 / SHP-2 interaction in myeloid cells in the context of tumor and the role of this axis in myeloid cell fate commitment and anti-tumor immunity. Methods: We generated mice with conditional deletion of Ptpn11 gene (encoding for Shp-2) in myeloid cells (Shp2f/fLysMCre), or T cells (Shp2f/fLckCre) and used Shp2f/f mice as control. We also used mice with myeloid-specific deletion of the Pdcd1 gene (encoding for PD-1). Tumor cells were injected subcutaneously and tumor growth was monitored. We used two different tumor cell lines: MC17- 51 fibrosarcoma and B16-F10 melanoma. At termination, tumors, spleens and bone marrows were collected, processed (details below), and immune populations were identified by flow cytometry. For cell isolation we used Fluorescence-Activated Cell Sorting (FACS) and magnetic beads and for signaling studies we used bone marrow cells cultured with GM-CSF and IL-3. Results: Mice with myeloid-specific SHP-2 ablation had significantly decelerated tumor growth compared to mice with T cell-specific SHP-2 ablation or control mice, but did not gain extra benefit from PD-1 blockade. SHP-2 deletion in myeloid cells resulted in T cell activation and myeloid cell activation and differentiation, while MDSCs had diminished suppressive properties and monocytes acquired lasting anti-tumor properties. Furthermore, by using RNA sequencing and gene set enrichment analysis in TAMs and PMN MDSCs, we demonstrated that SHP-2 deletion enriched gene pathways related to activation, differentiation, phagocytosis and antigen presentation in both these myeloid cell types. Myeloid specific PD-1 ablation had very similar effects in T cells and myeloid cells, and RNAseq of PD-1 deficient TAMs showed greater than 50% overlap in gene expression with SHP-2 deficient TAMs. Furthermore, we determined that in myeloid cells, GM-CSF induced phosphorylation of PD-1, recruited SHP-2 to the GM-CSF receptor and facilitated PD-1-SHP-2 interaction. Finally, either PD-1 or SHP-2 deletion enhanced GM-CSF-depended myeloid differentiation by abrogating SHP-2 medicated dephosphorylation of IRF8 and HOXA10. Conclusion: With the current study, we showed that PD-1-SHP-2 interaction can play a role in the differentiation of bone marrow myelocytes and myeloid cell progenitors and, subsequently, can affect their function and anti-tumor immunity.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Christofides, Anthos
  • Χριστοφίδης, Άνθος

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56646

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Christofides, Anthos; Χριστοφίδης, Άνθος. The role of PD-1 in macrophage polarization and fate commitment. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56646